How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

136,353 results for

Review of Systems

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

135661. Rhythmicity, synchronization and binding in human and primate motor systems (Full text)

Rhythmicity, synchronization and binding in human and primate motor systems This review focuses on recent advances in our understanding of temporal pattern coding in the motor systems of animals and man. Examples of millisecond time scale rhythmic synchronization in the visual system are considered. Results of experiments that demonstrate similar phenomena in the motor system are discussed. Finally problems concerning the nature of the correlation between neurophysiological signals

1998 The Journal of physiology

135662. Multiple System Atrophy : Clues from Inclusions (Full text)

Multiple System Atrophy : Clues from Inclusions 9736015 1998 09 24 2018 11 13 0002-9440 153 3 1998 Sep The American journal of pathology Am. J. Pathol. Multiple system atrophy: clues from inclusions. 671-6 Castellani R R Department of Pathology, University of Maryland, Baltimore 21201, USA. eng Comment Journal Article Review United States Am J Pathol 0370502 0002-9440 0 Myelin Basic Protein AIM IM Am J Pathol. 1998 Sep;153(3):735-44 9736024 Humans Male Multiple System Atrophy etiology

1998 The American journal of pathology

135663. Systemic thrombolysis causing anastomotic dehiscence of an aortobifemoral graft. (Full text)

Systemic thrombolysis causing anastomotic dehiscence of an aortobifemoral graft. 9849336 1998 12 18 2018 11 13 0035-8843 80 5 1998 Sep Annals of the Royal College of Surgeons of England Ann R Coll Surg Engl Systemic thrombolysis causing anastomotic dehiscence of an aortobifemoral graft. 343-6 Sequeira M J MJ Department of General Surgery, East Glamorgan General Hospital, Pontypridd. Shiralkar S S Edwards A T AT Lewis M H MH eng Case Reports Journal Article Research Support, Non-U.S. Gov't (...) Review England Ann R Coll Surg Engl 7506860 0035-8843 IM Ann R Coll Surg Engl. 1999 Jan;81(1):72 10325696 Aorta surgery Blood Vessel Prosthesis Female Femoral Artery surgery Humans Middle Aged Prosthesis Failure Surgical Wound Dehiscence etiology Thrombolytic Therapy adverse effects 11 1998 12 16 1998 12 16 0 1 1998 12 16 0 0 ppublish 9849336 PMC2503126 J Vasc Surg. 1986 Jun;3(6):936-8 2940380 AJR Am J Roentgenol. 1982 May;138(5):917-20 6211065 AJR Am J Roentgenol. 1984 Mar;142(3):573-4 6607648 BMJ

1998 Annals of the Royal College of Surgeons of England

135664. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus (Full text)

Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus 9893566 1999 01 25 2018 11 13 0003-4967 57 10 1998 Oct Annals of the rheumatic diseases Ann. Rheum. Dis. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. 573-7 Cutolo M M Department of Internal Medicine, University of Genova, Italy. Sulli A A Villaggio B B Seriolo B B Accardo S S eng Journal Article Review England Ann Rheum Dis (...) 0372355 0003-4967 0 Androgens 0 Cytokines 0 Gonadal Steroid Hormones IM Androgens physiology Arthritis, Rheumatoid physiopathology Cytokines physiology Female Gonadal Steroid Hormones physiology Humans Lupus Erythematosus, Systemic physiopathology Pregnancy Pregnancy Complications physiopathology 67 1999 1 20 1999 1 20 0 1 1999 1 20 0 0 ppublish 9893566 PMC1752484 Arthritis Rheum. 1992 Sep;35(9):1007-15 1418016 Immunol Today. 1992 Oct;13(10):379-81 1418371 Clin Exp Rheumatol. 1991 Nov-Dec;9(6):641-6

1998 Annals of the Rheumatic Diseases

135665. Intelligent CPAP systems: clinical experience (Full text)

Intelligent CPAP systems: clinical experience 10193363 1999 04 15 2018 12 01 0040-6376 53 Suppl 3 1998 Oct Thorax Thorax Intelligent CPAP systems: clinical experience. S49-54 Teschler H H Ruhrlandklinik, Abteilung Pneumologie-Universitätsklinik, Essen, Germany. Berthon-Jones M M eng Journal Article Review England Thorax 0417353 0040-6376 IM Alcohol Drinking Algorithms Electronic Data Processing Humans Positive-Pressure Respiration instrumentation methods Sleep Apnea Syndromes therapy 34 1999 4

1998 Thorax

135666. Second-line treatment for primary central nervous system lymphoma (Full text)

Second-line treatment for primary central nervous system lymphoma Failure after first-line treatment was reported in 35-60% of immunocompetent patients with primary central nervous system lymphoma (PCNSL). There are currently no reports focusing on salvage therapy. This review analyses prognostic factors and the efficacy of salvage therapy by focusing on data from papers reporting results of first-line treatment in 355 cases. The study group consisted of 173 patients presenting treatment

1999 British journal of cancer

135667. The innate immune system in cystic fibrosis lung disease (Full text)

The innate immune system in cystic fibrosis lung disease 9927489 1999 03 04 2018 11 13 0021-9738 103 3 1999 Feb The Journal of clinical investigation J. Clin. Invest. The innate immune system in cystic fibrosis lung disease. 303-7 Bals R R Institute for Human Gene Therapy, Departments of Medicine and Molecular and Cellular Engineering, The Wistar Institute, Philadelphia, Pennsylvania 19104-4268, USA. Weiner D J DJ Wilson J M JM eng Journal Article Review United States J Clin Invest 7802877 0021

1999 Journal of Clinical Investigation

135668. Making the most of rodent tumour systems in cancer drug discovery (Full text)

Making the most of rodent tumour systems in cancer drug discovery 10206270 1999 05 06 2018 11 13 0007-0920 79 11-12 1999 Apr British journal of cancer Br. J. Cancer Making the most of rodent tumour systems in cancer drug discovery. 1633-40 Bibby M C MC Clinical Oncology Unit, University of Bradford, West Yorkshire, UK. eng Journal Article Review England Br J Cancer 0370635 0007-0920 0 Antineoplastic Agents IM Animals Antineoplastic Agents pharmacokinetics therapeutic use Cell-Free System drug

1999 British journal of cancer

135669. Molecular Diagnosis of Herpes Simplex Virus Infections in the Central Nervous System (Full text)

Article Review United States J Clin Microbiol 7505564 0095-1137 0 DNA, Viral IM J Clin Microbiol. 2000 Feb;38(2):940 10722323 Central Nervous System Infections diagnosis therapy virology DNA, Viral cerebrospinal fluid Herpes Simplex diagnosis therapy Herpesviridae isolation & purification Humans Polymerase Chain Reaction 108 1999 6 12 10 0 2000 5 20 9 0 1999 6 12 10 0 ppublish 10364574 PMC85100 N Engl J Med. 1986 Jan 16;314(3):144-9 3001520 J Infect Dis. 1986 Apr;153(4):732-5 3005433 Ann Clin Lab Sci (...) Molecular Diagnosis of Herpes Simplex Virus Infections in the Central Nervous System 10364574 1999 07 09 2018 11 13 0095-1137 37 7 1999 Jul Journal of clinical microbiology J. Clin. Microbiol. Molecular diagnosis of herpes simplex virus infections in the central nervous system. 2127-36 Tang Y W YW Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. Mitchell P S PS Espy M J MJ Smith T F TF Persing D H DH eng Journal

1999 Journal of clinical microbiology

135670. Cell Migration in the Immune System: the Evolving Inter-Related Roles of Adhesion Molecules and Proteinases (Full text)

Cell Migration in the Immune System: the Evolving Inter-Related Roles of Adhesion Molecules and Proteinases Leukocyte extravasation into perivascular tissue during inflammation and lymphocyte homing to lymphoid organs involve transient adhesion to the vessel endothelium, followed by transmigration through the endothelial cell (EC) layer and establishment of residency at the tissue site for a period of time. In these processes, leukocytes undergo multiple attachments to, and detachments from (...) , the vessel-lining endothelial cells, prior to transendothelial cell migration. Transmigrating leukocytes must traverse a subendothelial basement membrane en route to perivascular tissues and utilize enzymes known as matrix metalloproteinases to make selective clips in the extracellular matrix components of the basement membrane. This review will focus on the evidence for a link between adhesion of leukocytes to endothelial cells, the induction of matrix metalloproteinases mediated by engagement

2000 Developmental immunology

135671. Is Bone a Target-Tissue for the Nervous System?: New Advances on the Understanding of Their Interactions (Full text)

Is Bone a Target-Tissue for the Nervous System?: New Advances on the Understanding of Their Interactions Bone cells respond in specific ways to various hormones and growth factors, but the biology of skeletal innervation and its physiologic significance in bone metabolism is poorly understood. With the introduction of immunohistochemical staining techniques and new molecular biology tools, the knowledge in this field has significantly improved. In this review, we update current understanding (...) of the effects of neuropeptides on bone metabolism, specifically vasoactive intestinal peptide (VIP) and calcitonin-gene related peptide (CGRP). In addition, new information concerning the role of growth factors, such as neurotrophins, is also discussed. There is strong evidence to suggest that bone can be a target of the nervous system. Further investigations in this field will allow us to answer questions related to pre-natal development, bone growth, fracture healing, osteoporosis, osteoarthritis

2000 The Iowa orthopaedic journal

135672. Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma

Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria DISEASE CHARACTERISTICS: Primary central nervous system non-Hodgkin's lymphoma (PCNSL) Clinically diagnosed intracranial space-occupying lesion Pathology consistent with non-Hodgkin's lymphoma and reviewed by NCCTG Biopsy optional if characteristic history, pathognomonic neuroimaging, and cytology are consistent with malignant lymphocytes from vitrectomy, CSF, or both No occult systemic lymphoma or prior lymphoma No post (...) Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

1999 Clinical Trials

135673. Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders

Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00004557 Recruitment Status : Completed First Posted : December 10, 2002 Last Update Posted : March 4, 2008 Sponsor: National Institute of Mental Health

2000 Clinical Trials

135674. Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus

Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00004663 Recruitment Status : Completed First Posted : February 25, 2000 Last Update Posted : June 24, 2005 Sponsor: National Center for Research

2000 Clinical Trials

135675. S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00002849 Recruitment Status : Completed First Posted : January 27, 2003 Last Update Posted : March 6, 2015 Sponsor

1999 Clinical Trials

135676. Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms

Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00015431 Recruitment

2001 Clinical Trials

135677. Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation

Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Evaluation of Eye (...) Movement Tracking Systems for Visual Rehabilitation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00013429 Recruitment Status : Completed First Posted : March 16, 2001 Last Update Posted : January 21, 2009 Sponsor: US Department of Veterans Affairs Information provided by: VA Office of Research

2001 Clinical Trials

135678. Monoclonal Antibody Treatment for Systemic Lupus Erythematosus

) will receive the lowest dose. If this dose is well tolerated, a second group (6 patients) will receive a higher dose. If this dose is also well tolerated, a third group (6 patients) will receive the highest study dose. Patients will be evaluated at various intervals for up to 3 months after the last dose of MRA. The follow-up visits will include a review of the patient s medical history, a physical examination, blood and urine tests, and an EKG. Condition or disease Intervention/treatment Phase Systemic (...) Monoclonal Antibody Treatment for Systemic Lupus Erythematosus Monoclonal Antibody Treatment for Systemic Lupus Erythematosus - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Monoclonal Antibody Treatment

2002 Clinical Trials

135679. The systemic inflammatory response: perspective of human endotoxemia. (PubMed)

The systemic inflammatory response: perspective of human endotoxemia. Improvements in detection of cytokines and other intermediary substances has allowed a new wave of investigations to determine the role that endotoxin plays in initiating these mediators. We have reviewed all studies of endotoxin administration (Escherichia coli, Lot EC-5, 4 ng/kg) to healthy humans in an effort to collate the currently available data that describes mediator elaboration and therapy directed against them. More

1996 Shock (Augusta, Ga.)

135680. Field test of a tool for level-of-care decisions in community mental health systems. (PubMed)

Field test of a tool for level-of-care decisions in community mental health systems. Tools for supporting decisions about placing clients in different levels of mental health care can facilitate several important functions, such as structuring service allocation, providing standards for quality assurance and concurrent review, designing service and benefit packages, and planning for resource needs. This paper describes a level-of-care decision-support tool and tests its reliability (...) and concurrent validity.Panels of clinical managers and administrators of mental health centers developed a decision-support tool with eight levels of care and a computerized decision-tree algorithm for level-of-care placement. A random sample of 1,034 adults from one county mental health system were assessed by their case managers using a package that included variables in the eight-level model, but not the algorithm itself. Other variables were included to assess the tool's concurrent validity.Level

1998 Psychiatric services (Washington, D.C.)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>